Cel-Sci
CVM
#9766
Rank
S$66.84 M
Marketcap
S$8.36
Share price
2.54%
Change (1 day)
-62.81%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$17.25 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are S$17.25 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30S$18.15 M-23.26%
2023-09-30S$23.65 M-10.26%
2022-09-30S$26.35 M0.35%
2021-09-30S$26.26 M-7.52%
2020-09-30S$28.39 M-8.64%
2019-09-30S$31.08 M-23.16%
2018-09-30S$40.45 M13.34%
2017-09-30S$35.69 M2.33%
2016-09-30S$34.87 M-26.46%
2015-09-30S$47.42 M323.01%
2014-09-30S$11.21 M115.84%
2013-09-30S$5.19 M-53.24%
2012-09-30S$11.11 M-10.4%
2011-09-30S$12.4 M-5.26%
2010-09-30S$13.08 M-75.14%
2009-09-30S$52.64 M852.09%
2008-09-30S$5.52 M-38.21%
2007-09-30S$8.94 M-46.76%
2006-09-30S$16.8 M907.17%
2005-09-30S$1.66 M-28.65%
2004-09-30S$2.33 M-19.95%
2003-09-30S$2.92 M-39.33%
2002-09-30S$4.81 M437.3%
2001-09-30S$0.89 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
S$54.88 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.08 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.39 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.31 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.26 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$147.19 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.13 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$3.37 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA